Search Results

There are 11648 results for: content related to: Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study

  1. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

    Addiction

    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:

    Erratum

    Vol. 105, Issue 7, 1322, Version of Record online: 8 JUN 2010

  2. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  3. Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  4. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  5. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

    The Milbank Quarterly

    Volume 93, Issue 3, September 2015, Pages: 561–583, BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL and ANDREW W. DICK

    Version of Record online : 8 SEP 2015, DOI: 10.1111/1468-0009.12137

  6. Buprenorphine for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD002025.pub4

  7. You have free access to this content
    Buprenorphine for treating cancer pain

    Intervention Review

    The Cochrane Library

    Mia Schmidt-Hansen, Nathan Bromham, Mark Taubert, Stephanie Arnold and Jennifer S Hilgart

    Published Online : 31 MAR 2015, DOI: 10.1002/14651858.CD009596.pub4

  8. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  9. Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

    Addiction Biology

    Volume 20, Issue 4, July 2015, Pages: 784–798, Jermaine D. Jones, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne M. Manubay, Shanthi Mogali, Verena Metz and Sandra D. Comer

    Version of Record online : 24 JUL 2014, DOI: 10.1111/adb.12163

  10. Buprenorphine

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 514–526, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch28

  11. The clinical use of buprenorphine in opiate addiction: evidence and practice

    Acta Neuropsychiatrica

    Volume 16, Issue 5, October 2004, Pages: 246–274, Fergus D. Law, Judy S. Myles, Mark R. C. Daglish and David J. Nutt

    Version of Record online : 11 FEB 2005, DOI: 10.1111/j.0924-2708.2004.00095.x

  12. You have free access to this content
    Buprenorphine: An Analgesic with an Expanding Role in the Treatment of Opioid Addiction

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 377–390, Susan E. Robinson

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00235.x

  13. The history of the development of buprenorphine as an addiction therapeutic

    Annals of the New York Academy of Sciences

    Volume 1248, Issue 1, February 2012, Pages: 124–139, Nancy D. Campbell and Anne M. Lovell

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06352.x

  14. Buprenorphine in Maintenance Treatment: Experience among Italian Physicians in Drug Addiction Centers

    The American Journal on Addictions

    Volume 19, Issue 3, May-June 2010, Pages: 222–230, Gianluca Quaglio, Cristian Pattaro, Gilberto Gerra, Paolo Mezzelani, Linda Montanari, Don C. Des Jarlais and Fabio Lugoboni

    Version of Record online : 2 APR 2010, DOI: 10.1111/j.1521-0391.2010.00040.x

  15. Conversion from High-Dose Full-Opioid Agonists to Sublingual Buprenorphine Reduces Pain Scores and Improves Quality of Life for Chronic Pain Patients

    Pain Medicine

    Volume 15, Issue 12, December 2014, Pages: 2087–2094, Danielle Daitch, Jonathan Daitch, Daniel Novinson, Michael Frey, Carol Mitnick and Joseph Pergolizzi Jr

    Version of Record online : 12 SEP 2014, DOI: 10.1111/pme.12520

  16. You have free access to this content
    Detoxification treatments for opiate dependent adolescents

    Intervention Review

    The Cochrane Library

    Silvia Minozzi, Laura Amato, Cristina Bellisario and Marina Davoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD006749.pub3

  17. The novel depot of buprenorphine propionate has a long-acting effect on physical dependence on morphine

    Drug Development Research

    Volume 67, Issue 5, May 2006, Pages: 462–469, Kuo-Sheng Liu, Ching-Nan Lin, Ja-Ping Shieh, Chin-Chen Chu, Chun-Hsiung Kuei and Jhi-Joung Wang

    Version of Record online : 19 SEP 2006, DOI: 10.1002/ddr.20107

  18. Pharmacokinetics of morphine and its surrogates X: Analyses and pharmacokinetics of buprenorphine in dogs

    Biopharmaceutics & Drug Disposition

    Volume 11, Issue 4, May/June 1990, Pages: 311–350, Edward R. Garrett and V. Ravi Chandran

    Version of Record online : 11 JAN 2006, DOI: 10.1002/bdd.2510110403

  19. You have free access to this content
    Effects of Various Combinations of Benzodiazepines with Buprenorphine on Arterial Blood Gases in Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 103, Issue 3, September 2008, Pages: 228–239, Stéphane O. Pirnay, Bruno Mégarbane, Stephen W. Borron, Patricia Risède, Claire Monier, Ivan Ricordel and Frédéric J. Baud

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1742-7843.2008.00273.x

  20. “Sub is a weird drug:” A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms

    The American Journal on Addictions

    Volume 24, Issue 5, August 2015, Pages: 403–409, Raminta Daniulaityte, Robert Carlson, Gregory Brigham, Delroy Cameron and Amit Sheth

    Version of Record online : 25 MAY 2015, DOI: 10.1111/ajad.12213